Recently, the Wall Street Journal reported that Swiss biopharmaceutical company Roche is acquiring US technology company Spark Theraputics, which may be announced on Monday. The acquisition will value Sparks nearly $5 billion, while the Nasd

GE has agreed to sell its BioPharma business to Danaher Corporation for $21.4 billion, adding biopharmaceutical research, development, and manufacturing instruments, equipment, and consumables to Danahers Life Science group, which includes P

NEW YORK (GenomeWeb) Illumina plans to acquire Pacific Biosciences for approximately $1.2 billion in cash, the companies said on Thursday. Under the agreement, which has been approved by both companies boards of directors, Illumina will pay

NeoGenomics recently announced a definitive agreement to acquire clinical oncology laboratory Genoptix for $125 million in cash and 1 million shares of NeoGenomics stock. Based in Carlsbad, California, Genoptix specializes on hematology and

NEW YORK (GenomeWeb) Agilent Technologies announced today that it has agreed to acquire ACEA Biosciences for $250 million in cash. Privately held ACEA, which is based in San Diego, has most recently developed a line of xCELLigence impedance-